RxDoctor Payments Data

Jaclyn Liston-Crandall, MD

Family Medicine · Tekonsha, MINPI 1114145133

Payments from drug & device makers

$316in general payments, 2019–2025

Across 22 payments — averaging $14.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$126
  • AbbVie$33
  • Takeda Pharmaceuticals U.S.A., Inc.$32
  • GSK$19
  • Johnson & Johnson$18
  • Boehringer Ingelheim$15
  • plus $73 from 6 others

What the payments were for

  • Food & beverage$30195%
  • Education$155%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$316 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$25,756
Medicare patients
86
Services billed
407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$58,789
JardianceEmpagliflozin25$34,025
EliquisApixaban39$32,732
FarxigaDapagliflozin Propanediol19$21,333
TrulicityDulaglutide18$19,863
MounjaroTirzepatide19$19,674
LinzessLinaclotide14$16,146
XareltoRivaroxaban20$15,165
MyrbetriqMirabegron14$14,932
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$13,883
JanuviaSitagliptin Phosphate17$13,617
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen223$6,087
Atorvastatin Calcium334$4,151
Duloxetine Hcl142$3,625
Levothyroxine Sodium280$3,176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$126$58,78936 claims
Boehringer IngelheimJardiance$15$34,02525 claims
PfizerEliquis$12$32,73239 claims
AstraZenecaFarxiga$12$21,33319 claims
AbbVieLinzess$33$16,14614 claims
Johnson & JohnsonXarelto$18$15,16520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Tekonsha

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →